Chronic Wasting Disease Vaccines
慢性消耗性疾病疫苗
基本信息
- 批准号:10295244
- 负责人:
- 金额:$ 71.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-08 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdjuvantAmericanAnimalsAntigensAsiaBiological AssayBloodBrainCattleCellular ImmunityChronic Wasting DiseaseCombined VaccinesConsumptionDataDeerDevelopmentDiseaseDisease OutbreaksDoseEnvironmental PollutionEnzyme-Linked Immunosorbent AssayEuthanasiaExcretory functionFecesFlow CytometryHealthHumanHumoral ImmunitiesImmune responseImmunizationImmunizeImmunoglobulin GImmunohistochemistryIndustryInfectionInflammationMacacaModelingMolecular ConformationMonitorNeurodegenerative DisordersNorth AmericaOralOutcomePathologicPeripheral Blood Mononuclear CellPersonal SatisfactionPrPPrPSc ProteinsPractice ManagementPrion DiseasesPrionsProtein IsoformsPublic HealthRNARegimenReindeerResearchRiskSafetySalivaStainsStructureSystemTailTestingTherapeuticTimeTissuesTransgenic MiceUrineVaccinatedVaccinationVaccine DesignVaccinesZoonosesanti-IgAanti-PrP antibodiescervidcohortcomparativeconformercytokinedetection methodhealth economicsinnovationnonhuman primatenovelnovel vaccinesoverexpressionprophylacticprototypeside effecttooltranslational impacttransmission processvaccine candidate
项目摘要
PROJECT SUMMARY / ABSTRACT
No prophylactic or therapeutic regimen is known for any prion disease. The BSE outbreak in cattle with
the subsequent emergence of a new and transmissible human prion disease (vCJD) highlights the public
health threat from prion diseases. The commonalities among mammalian prion diseases are quite
remarkable 1. The ongoing and expanding major threat from prion disease in North America is chronic
wasting disease (CWD). CWD is an emergent rapidly spreading disease in cervids 2 with uncertain zoonotic
potential 3. Approximately 9 million Americans hunt deer and elk 4 with an estimated 7,000-15,000 CWD-
infected cervids consumed annually (increasing 20%/yr) 5. As hunting is a roughly $26 billion (per annum) 4
industry, CWD also represents an enormous potential health and economic threat. We have developed novel
vaccine strategies which show promise in animal models 6-8 and have established a carefully-graded CWD
challenge 9,10 in tandem with a longitudinal monitoring system in our unique indoor-housed white-tailed deer
facility 10-14, permitting CWD vaccine assessment in the native host.
We propose 3 aims to determine the ability of homologous or heterologous immunization strategies to protect
deer from CWD infection and mitigate prion shedding. In Aim 1 we will determine the efficacy and safety of
CWD vaccines that have complementary targets, a highly innovative and rationally designed vaccine which
targets PrPSc 8,15 and a second vaccine strategy which aims at eliminating the substrate for prion conversion
7,16, and whether combining the vaccines is more effective. In Aim 2 we will determine if these vaccine
strategies, alone or in combination, protect deer from CWD infection. Aim 3 will further determine if vaccination
reduces prion shedding in excreta and secreta (urine, feces and saliva) of CWD challenged deer, thereby
reducing infection between cervids and environmental contamination.
The translational impact of the results of these studies will:
a) develop prototype vaccine candidates for prion diseases
b) provide management tools for the cervid industry and wildlife management
c) mitigate the risks of zoonotic transmission of cervid prions.
Thereby, this research will have immediate impacts in both human and animal health.
项目概要/摘要
对于任何朊病毒疾病,尚无已知的预防或治疗方案。牛中疯牛病的爆发
随后出现的一种新型传染性人类朊病毒病(vCJD)引起了公众的关注
朊病毒疾病的健康威胁。哺乳动物朊病毒疾病的共同点相当多
值得注意的是 1. 北美地区朊病毒病的主要威胁是长期存在且不断扩大
消耗性疾病(CWD)。 CWD 是一种在鹿科动物中迅速传播的新疾病 2,具有不确定的人畜共患疾病
潜力 3. 大约 900 万美国人狩猎鹿和麋鹿 4,估计有 7,000-15,000 CWD-
每年消耗受感染的鹿科动物(每年增加 20%)5. 由于狩猎价值约为 260 亿美元(每年)4
工业界,CWD 还代表着巨大的潜在健康和经济威胁。我们开发了新颖的
疫苗策略在动物模型 6-8 中显示出希望,并建立了仔细分级的 CWD
与我们独特的室内白尾鹿的纵向监测系统一起挑战 9,10
设施 10-14,允许在本地宿主中评估 CWD 疫苗。
我们提出了 3 个目标来确定同源或异源免疫策略的保护能力
鹿免受 CWD 感染并减少朊病毒脱落。在目标 1 中,我们将确定以下药物的有效性和安全性:
具有互补靶点的 CWD 疫苗,是一种高度创新且设计合理的疫苗,
针对 PrPSc 8,15 和旨在消除朊病毒转化底物的第二种疫苗策略
7,16,以及联合疫苗是否更有效。在目标 2 中,我们将确定这些疫苗是否
单独或组合的策略可以保护鹿免受 CWD 感染。目标 3 将进一步确定是否接种疫苗
减少 CWD 感染鹿的排泄物和分泌物(尿液、粪便和唾液)中朊病毒的脱落,从而
减少鹿科动物之间的感染和环境污染。
这些研究结果的转化影响将:
a) 开发朊病毒疾病候选原型疫苗
b) 为鹿科动物产业和野生动物管理提供管理工具
c) 降低鹿科朊病毒人畜共患病传播的风险。
因此,这项研究将对人类和动物健康产生直接影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Candace K. Mathiason其他文献
Candace K. Mathiason的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Candace K. Mathiason', 18)}}的其他基金
Detection and Characterization of Blood-borne Prions
血源性朊病毒的检测和表征
- 批准号:
10625408 - 财政年份:2014
- 资助金额:
$ 71.61万 - 项目类别:
Detection and Characterization of Blood-borne Prions
血源性朊病毒的检测和表征
- 批准号:
10408819 - 财政年份:2014
- 资助金额:
$ 71.61万 - 项目类别:
Detection and Characterization of Blood-borne Prions
血源性朊病毒的检测和表征
- 批准号:
10201450 - 财政年份:2014
- 资助金额:
$ 71.61万 - 项目类别:
Detection and Characterization of Blood-borne Prions
血源性朊病毒的检测和表征
- 批准号:
8748831 - 财政年份:2014
- 资助金额:
$ 71.61万 - 项目类别:
Detection and Characterization of Blood-borne Prions
血源性朊病毒的检测和表征
- 批准号:
9066080 - 财政年份:2014
- 资助金额:
$ 71.61万 - 项目类别:
Detection and Characterization of Blood-borne Prions
血源性朊病毒的检测和表征
- 批准号:
9277356 - 财政年份:2014
- 资助金额:
$ 71.61万 - 项目类别:
Mother to Offspring Transmission of Chronic Wasting Disease
慢性消耗性疾病的母婴传播
- 批准号:
8193075 - 财政年份:2011
- 资助金额:
$ 71.61万 - 项目类别:
Mother to Offspring Transmission of Chronic Wasting Disease
慢性消耗性疾病的母婴传播
- 批准号:
8470544 - 财政年份:2011
- 资助金额:
$ 71.61万 - 项目类别:
相似海外基金
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 71.61万 - 项目类别:
Development of an Opioid Sparing Therapeutic to Minimize Opioid Use Disorderand Tolerance in the Treatment of Pain
开发阿片类药物节约疗法,以最大限度地减少阿片类药物使用障碍和疼痛治疗耐受性
- 批准号:
10760487 - 财政年份:2023
- 资助金额:
$ 71.61万 - 项目类别:
Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain
治疗骨关节炎疼痛的新型全身候选药物的临床前评估
- 批准号:
10642544 - 财政年份:2023
- 资助金额:
$ 71.61万 - 项目类别:
Discovery and characterization of a novel natural product for the treatment of both diabetes and obesity
用于治疗糖尿病和肥胖症的新型天然产品的发现和表征
- 批准号:
10737170 - 财政年份:2023
- 资助金额:
$ 71.61万 - 项目类别:
Project 3: Credentialing CDK 4/6 inhibitors used with radiation as an effective treatment strategy in locally advanced ER+ and TNBC
项目 3:认证 CDK 4/6 抑制剂与放射结合使用作为局部晚期 ER 和 TNBC 的有效治疗策略
- 批准号:
10554474 - 财政年份:2023
- 资助金额:
$ 71.61万 - 项目类别: